



A cancer molecular test that incorporates a 500+ tumor-related multi-gene panel associated with targeted therapies.



A test that fully analyzes a panel of genes, including BRCA1 and BRCA2, which are responsible for increased risk of developing breast, ovarian, and other hereditary cancers.
Sciphram Trading FZCO
High-sensitivity testing for Cancer diagnosis and treatment planning.
At Scipharm, we are committed to revolutionizing the field of molecular medicine by providing cutting-edge tumor profiling and targeted therapy solutions. Established in 2021 in the UAE, our mission is to enhance precision medicine options with the highest quality services, empowering physicians to make informed treatment decisions.
capabilitiesIdentifying genetic alterations for targeted therapies
Molecular Genetics
Our labs is specialized in molecular genetics. Utilizing cutting edge technology, our company offers all the validated molecular tools for the diagnosis, prognosis and individualized treatment of cancer patients.
Oncology
It is generally accepted that cancer is a disease with a genetic background related to acquired or hereditary mutations, gene translocations and over expression of some genes. Mutations take place in genes that are responsible for the smooth operation of the organism with regards to the cellular proliferation, differentiation and cellular death. The majority of cancers is sporadic and is presented in relatively elder people, as they occur from the accumulation of mutations in genes such as K-RAS, EGFR, BRAF, P53 etc. Such mutations are also related to response to targeted therapies.
servicesEnhancing patient outcomes through individualized care
about usComprehensive Tumor Profiling & Targeted Therapy Solutions.
At Scipharm, we are committed to revolutionizing the field of molecular medicine by providing cutting-edge tumor profiling and targeted therapy solutions. Established in 2021 in the UAE, our mission is to enhance precision medicine options with the highest quality services, empowering physicians to make informed treatment decisions.
Through our strategic partnership with Genekor, a globally recognized leader in molecular medicine quality assurance, we bring highly sensitive and specific molecular assays to clinical practice, ensuring accuracy and reliability in cancer diagnostics.
European data
European data
TODAY
- solutions for specific needs
- Advanced data analysis and services
- Comprehensive interpretation and reporting results
- CAP accredited European lab.with cutting edge Technologies
- One of the top 17 word wide labs (data: nature genetics in Medicine)
TOMORROW
- Blood screening test for all cancers
- AI for prognostic and predictive breast cancer
- Health and well being for Everyman and Everywoman







